Reflections on the Nobel Prize for Medicine 2015 - The Public Health Legacy and Impact of Avermectin and Artemisinin

Trends in Parasitology

Volumn 31, Issue 12, 2015, Pages 605-607

  Molyneux, David H ^a   Ward, Steve A ^a  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ARTEMISININ; AVERMECTIN; IVERMECTIN; MEFLOQUINE; ANTIPARASITIC AGENT; ARTEMISININ DERIVATIVE;

AFRICAN TRYPANOSOMIASIS; ARTEMISIA ANNUA; AWARDS AND PRIZES; CLINICAL TRIAL (TOPIC); DRUG EFFICACY; DRUG INDUSTRY; DRUG SAFETY; HEALTH CARE POLICY; HUMAN; LEISHMANIASIS; LEPROSY; LYMPHATIC FILARIASIS; MALARIA CONTROL; NONHUMAN; NOTE; ONCHOCERCA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PARASITE TRANSMISSION; PARASITOSIS; PUBLIC HEALTH PROBLEM; SCHISTOSOMIASIS; TRACHOMA; TREATMENT OUTCOME; VISUAL IMPAIRMENT; ANALOGS AND DERIVATIVES; ANIMAL; ECONOMICS; HEALTH; HISTORY; PARASITIC DISEASES; PUBLIC HEALTH; TRENDS; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIPARASITIC AGENTS; ARTEMISININS; DRUG INDUSTRY; GLOBAL HEALTH; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; IVERMECTIN; NOBEL PRIZE; PARASITIC DISEASES; PUBLIC HEALTH; WORLD HEALTH ORGANIZATION;

EID: 84949217188     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2015.10.008     Document Type: Note

References (11)

1. Campbell W.C. The genesis of antiparasitic drug ivermectin. Inventive Minds 1992, 194-214. Oxford University Press. R.J. Weber, D.N. Perkins (Eds.).
2. Aziz M.A., et al. Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet 1982, 2:1456-1457.
3. Campbell W.C. Ivermectin as an antiparasitic agent for use in humans. Annu. Rev. Microbiol. 1991, 45:445-474.
4. Awadzi K. The chemotherapy of onchocerciasis XI: a double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana. Ann. Trop. Med. Parasitol. 1986, 80:433-444.
5. Liese B., et al. Programmes, partnerships, and governance for elimination and control of neglected tropical diseases. Lancet 2010, 375:67-76.
6. Molyneux D.H. Neglected tropical diseases: now more than just 'other diseases'- the post-2015 agenda. Int. Health 2014, 6:172-180.
7. Cross C., et al. Historical profiles and perspectives from river blindness to neglected tropical diseases - lessons learned in Africa for programme implementation and expansion by the non-governmental partners. PLoS Negl. Trop. Dis. 2015, 9:e0003506.
8. Klayman D.L. Qinghaosu (Artemisinin): an antimalarial drug from China. Science 1985, 228:1049-1055.
9. Makanga M. A review of the effects of artemether-lumefantrine on gametocyte carriage and disease transmission. Malar. J. 2014, 13:291.
10. World Health Organization (2014) World Malaria Report, WHO.
11. Sachs J., Malaney P. The economic and social burden of malaria. Nature 2002, 415:680-685.